Sara Miller
Concepts (704)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wasps | 7 | 2023 | 21 | 2.930 |
Why?
| | Selection, Genetic | 6 | 2025 | 268 | 2.680 |
Why?
| | Cognition | 7 | 2025 | 1168 | 1.910 |
Why?
| | Biological Evolution | 6 | 2025 | 485 | 1.910 |
Why?
| | Smegmamorpha | 4 | 2019 | 6 | 1.870 |
Why?
| | Alcohol Drinking | 6 | 2025 | 815 | 1.840 |
Why?
| | Behavior, Animal | 4 | 2021 | 506 | 1.270 |
Why?
| | Coronavirus | 2 | 2020 | 48 | 1.250 |
Why?
| | Coronavirus Infections | 5 | 2020 | 367 | 1.170 |
Why?
| | Microscopy, Electron | 11 | 2022 | 435 | 1.160 |
Why?
| | Pneumonia, Viral | 4 | 2020 | 369 | 1.060 |
Why?
| | Memory Disorders | 3 | 2023 | 171 | 0.980 |
Why?
| | Surgery, Computer-Assisted | 3 | 2018 | 72 | 0.940 |
Why?
| | Pandemics | 7 | 2024 | 1627 | 0.920 |
Why?
| | Microscopy, Electron, Transmission | 6 | 2021 | 157 | 0.900 |
Why?
| | Substance-Related Disorders | 3 | 2023 | 1058 | 0.900 |
Why?
| | Genetic Fitness | 1 | 2025 | 59 | 0.900 |
Why?
| | Academic Performance | 1 | 2024 | 16 | 0.850 |
Why?
| | Optical Imaging | 3 | 2019 | 62 | 0.840 |
Why?
| | Diabetes, Gestational | 2 | 2025 | 320 | 0.810 |
Why?
| | Individuality | 1 | 2025 | 158 | 0.810 |
Why?
| | Amnesia, Anterograde | 1 | 2023 | 4 | 0.810 |
Why?
| | Prescription Drug Misuse | 1 | 2023 | 45 | 0.760 |
Why?
| | Placenta Accreta | 1 | 2022 | 27 | 0.760 |
Why?
| | Betacoronavirus | 4 | 2020 | 270 | 0.740 |
Why?
| | Archives | 1 | 2021 | 5 | 0.730 |
Why?
| | Ethology | 1 | 2021 | 2 | 0.710 |
Why?
| | Entomology | 1 | 2021 | 4 | 0.710 |
Why?
| | Cellular Structures | 1 | 2021 | 6 | 0.700 |
Why?
| | Data Curation | 1 | 2021 | 17 | 0.700 |
Why?
| | Life History Traits | 1 | 2021 | 16 | 0.690 |
Why?
| | Insecta | 1 | 2021 | 70 | 0.680 |
Why?
| | Humans | 91 | 2025 | 137601 | 0.680 |
Why?
| | Behavior, Addictive | 1 | 2021 | 80 | 0.680 |
Why?
| | Genetic Variation | 4 | 2024 | 1001 | 0.670 |
Why?
| | Erythrocyte Transfusion | 1 | 2022 | 197 | 0.670 |
Why?
| | Gestational Age | 1 | 2024 | 913 | 0.670 |
Why?
| | Genome | 2 | 2022 | 299 | 0.660 |
Why?
| | Animal Communication | 1 | 2020 | 18 | 0.660 |
Why?
| | Infant, Premature | 2 | 2024 | 579 | 0.650 |
Why?
| | Ecology | 1 | 2021 | 119 | 0.640 |
Why?
| | Academic Success | 1 | 2019 | 29 | 0.630 |
Why?
| | Food Chain | 2 | 2019 | 42 | 0.610 |
Why?
| | Animals | 45 | 2025 | 37088 | 0.610 |
Why?
| | Infant, Low Birth Weight | 1 | 2019 | 141 | 0.600 |
Why?
| | Perciformes | 1 | 2019 | 19 | 0.600 |
Why?
| | Animal Distribution | 1 | 2019 | 24 | 0.590 |
Why?
| | Hip | 1 | 2018 | 56 | 0.560 |
Why?
| | Sex Characteristics | 1 | 2023 | 765 | 0.560 |
Why?
| | Diagnostic Techniques, Ophthalmological | 1 | 2017 | 48 | 0.530 |
Why?
| | Optic Nerve Diseases | 1 | 2017 | 45 | 0.520 |
Why?
| | Optic Disk | 1 | 2017 | 47 | 0.520 |
Why?
| | Photography | 1 | 2017 | 107 | 0.520 |
Why?
| | Amputees | 1 | 2018 | 97 | 0.510 |
Why?
| | Stress, Psychological | 1 | 2025 | 1118 | 0.500 |
Why?
| | Caregivers | 2 | 2021 | 904 | 0.500 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1299 | 0.490 |
Why?
| | Child Development | 2 | 2019 | 468 | 0.480 |
Why?
| | Female | 46 | 2025 | 73359 | 0.480 |
Why?
| | Postural Balance | 1 | 2018 | 218 | 0.470 |
Why?
| | United States | 13 | 2025 | 14925 | 0.470 |
Why?
| | Students, Medical | 5 | 2021 | 355 | 0.470 |
Why?
| | Gait | 1 | 2018 | 297 | 0.460 |
Why?
| | Executive Function | 1 | 2019 | 448 | 0.450 |
Why?
| | Ecosystem | 1 | 2019 | 576 | 0.440 |
Why?
| | Artificial Limbs | 1 | 2018 | 201 | 0.440 |
Why?
| | Glioblastoma | 1 | 2018 | 340 | 0.440 |
Why?
| | Phenotype | 5 | 2023 | 3150 | 0.430 |
Why?
| | Molecular Imaging | 3 | 2019 | 57 | 0.430 |
Why?
| | Glaucoma | 1 | 2017 | 233 | 0.430 |
Why?
| | Lower Extremity | 1 | 2018 | 435 | 0.420 |
Why?
| | Genetics, Population | 3 | 2020 | 208 | 0.420 |
Why?
| | Male | 37 | 2025 | 67690 | 0.410 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2021 | 841 | 0.400 |
Why?
| | Neoplasms | 2 | 2021 | 2691 | 0.360 |
Why?
| | Catheter-Related Infections | 1 | 2012 | 89 | 0.350 |
Why?
| | General Surgery | 3 | 2018 | 173 | 0.350 |
Why?
| | Lung | 2 | 2022 | 4057 | 0.350 |
Why?
| | Bioterrorism | 3 | 2009 | 30 | 0.340 |
Why?
| | Education, Medical, Undergraduate | 3 | 2018 | 190 | 0.340 |
Why?
| | Genome, Insect | 2 | 2021 | 23 | 0.340 |
Why?
| | Infection Control | 1 | 2012 | 163 | 0.340 |
Why?
| | Catheterization, Central Venous | 1 | 2012 | 113 | 0.340 |
Why?
| | Comprehensive Health Care | 1 | 2010 | 24 | 0.340 |
Why?
| | National Health Programs | 2 | 2009 | 21 | 0.330 |
Why?
| | Public Policy | 1 | 2010 | 83 | 0.330 |
Why?
| | Endocytosis | 3 | 2022 | 175 | 0.320 |
Why?
| | Bacteremia | 1 | 2012 | 214 | 0.320 |
Why?
| | Curriculum | 5 | 2021 | 1002 | 0.320 |
Why?
| | Social Behavior | 3 | 2023 | 289 | 0.320 |
Why?
| | Health Plan Implementation | 1 | 2010 | 142 | 0.310 |
Why?
| | Mitochondria, Heart | 2 | 2025 | 100 | 0.310 |
Why?
| | Fluorescent Dyes | 4 | 2019 | 318 | 0.290 |
Why?
| | Brain Neoplasms | 1 | 2018 | 1266 | 0.290 |
Why?
| | Dental Implantation, Endosseous | 1 | 2008 | 3 | 0.290 |
Why?
| | Dental Prosthesis, Implant-Supported | 1 | 2008 | 7 | 0.290 |
Why?
| | Intraoperative Care | 2 | 2019 | 58 | 0.290 |
Why?
| | Career Choice | 3 | 2020 | 227 | 0.270 |
Why?
| | Viruses | 1 | 2009 | 161 | 0.270 |
Why?
| | Virus Diseases | 1 | 2009 | 212 | 0.260 |
Why?
| | BK Virus | 3 | 2013 | 17 | 0.260 |
Why?
| | Myocytes, Cardiac | 2 | 2025 | 505 | 0.260 |
Why?
| | Polyomavirus Infections | 3 | 2013 | 31 | 0.260 |
Why?
| | Tumor Virus Infections | 3 | 2013 | 50 | 0.260 |
Why?
| | Child Behavior | 2 | 2019 | 245 | 0.250 |
Why?
| | Glucose Tolerance Test | 2 | 2025 | 366 | 0.250 |
Why?
| | Prospective Studies | 5 | 2023 | 7580 | 0.250 |
Why?
| | Middle Aged | 13 | 2025 | 33441 | 0.250 |
Why?
| | Infant, Newborn | 6 | 2024 | 6125 | 0.240 |
Why?
| | Endodontists | 1 | 2025 | 1 | 0.240 |
Why?
| | Endodontics | 1 | 2025 | 4 | 0.240 |
Why?
| | Technology, Dental | 1 | 2025 | 5 | 0.240 |
Why?
| | Blood Glucose | 3 | 2025 | 2188 | 0.230 |
Why?
| | Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2025 | 2 | 0.230 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2025 | 5 | 0.230 |
Why?
| | Longitudinal Studies | 3 | 2024 | 2836 | 0.230 |
Why?
| | Pregnancy | 5 | 2025 | 6770 | 0.230 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2019 | 265 | 0.230 |
Why?
| | Surveys and Questionnaires | 5 | 2025 | 5835 | 0.230 |
Why?
| | Printing, Three-Dimensional | 1 | 2025 | 90 | 0.220 |
Why?
| | Antigens, Surface | 1 | 2025 | 153 | 0.220 |
Why?
| | Adult | 16 | 2025 | 37910 | 0.220 |
Why?
| | Cytotoxicity, Immunologic | 1 | 2025 | 225 | 0.220 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 52 | 0.220 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2025 | 118 | 0.220 |
Why?
| | Apolipoprotein L1 | 1 | 2024 | 13 | 0.210 |
Why?
| | Autophagy | 4 | 2010 | 286 | 0.210 |
Why?
| | Spectroscopy, Near-Infrared | 3 | 2019 | 64 | 0.210 |
Why?
| | Cetuximab | 3 | 2019 | 98 | 0.210 |
Why?
| | Fibroblast Growth Factors | 1 | 2025 | 177 | 0.210 |
Why?
| | Virion | 2 | 2020 | 113 | 0.210 |
Why?
| | alpha-Synuclein | 1 | 2023 | 40 | 0.210 |
Why?
| | Haploidy | 1 | 2023 | 27 | 0.200 |
Why?
| | Variola virus | 1 | 2003 | 3 | 0.200 |
Why?
| | Transport Vesicles | 2 | 2018 | 20 | 0.200 |
Why?
| | Diploidy | 1 | 2023 | 19 | 0.200 |
Why?
| | Adenosine Triphosphatases | 3 | 2009 | 158 | 0.200 |
Why?
| | Smallpox | 1 | 2003 | 10 | 0.200 |
Why?
| | Substance Abuse, Intravenous | 1 | 2024 | 117 | 0.200 |
Why?
| | Herpesviridae | 1 | 2003 | 23 | 0.200 |
Why?
| | Vaping | 1 | 2024 | 60 | 0.200 |
Why?
| | Mass Screening | 2 | 2025 | 1279 | 0.200 |
Why?
| | Disaster Planning | 2 | 2006 | 91 | 0.200 |
Why?
| | Virus Replication | 3 | 2023 | 528 | 0.200 |
Why?
| | Health Care Surveys | 1 | 2025 | 562 | 0.200 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3287 | 0.200 |
Why?
| | Carrier Proteins | 2 | 2022 | 736 | 0.200 |
Why?
| | Obstetrics | 1 | 2025 | 171 | 0.200 |
Why?
| | Feeding Behavior | 2 | 2019 | 684 | 0.200 |
Why?
| | Guinea | 1 | 2022 | 3 | 0.200 |
Why?
| | Ventricular Remodeling | 1 | 2025 | 253 | 0.190 |
Why?
| | Parents | 2 | 2024 | 1419 | 0.190 |
Why?
| | Internal-External Control | 1 | 2023 | 74 | 0.190 |
Why?
| | Aged | 8 | 2025 | 23938 | 0.190 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2024 | 103 | 0.190 |
Why?
| | Cell Cycle Proteins | 4 | 2018 | 614 | 0.190 |
Why?
| | Immunosenescence | 1 | 2022 | 5 | 0.190 |
Why?
| | Clinical Competence | 3 | 2020 | 1122 | 0.190 |
Why?
| | Retrospective Studies | 6 | 2023 | 15720 | 0.190 |
Why?
| | Nucleocapsid | 1 | 2022 | 18 | 0.190 |
Why?
| | Gene Frequency | 1 | 2023 | 504 | 0.190 |
Why?
| | Hysterectomy | 1 | 2022 | 134 | 0.180 |
Why?
| | Herpesviridae Infections | 1 | 2003 | 148 | 0.180 |
Why?
| | Nephrotic Syndrome | 1 | 2022 | 38 | 0.180 |
Why?
| | Muscle Proteins | 3 | 2008 | 237 | 0.180 |
Why?
| | Pediatric Obesity | 2 | 2019 | 591 | 0.180 |
Why?
| | Ethanol | 2 | 2023 | 614 | 0.180 |
Why?
| | Natural History | 1 | 2021 | 5 | 0.180 |
Why?
| | Killer Cells, Natural | 1 | 2025 | 451 | 0.180 |
Why?
| | Receptors, Odorant | 1 | 2021 | 32 | 0.180 |
Why?
| | Podocytes | 1 | 2022 | 67 | 0.180 |
Why?
| | Cesarean Section | 1 | 2022 | 187 | 0.170 |
Why?
| | Models, Biological | 5 | 2020 | 1783 | 0.170 |
Why?
| | Autopsy | 1 | 2021 | 94 | 0.170 |
Why?
| | Mice | 19 | 2025 | 17748 | 0.170 |
Why?
| | Nanospheres | 1 | 2020 | 1 | 0.170 |
Why?
| | Thorax | 1 | 2020 | 47 | 0.170 |
Why?
| | Cities | 1 | 2021 | 132 | 0.170 |
Why?
| | Myositis, Inclusion Body | 3 | 2010 | 11 | 0.170 |
Why?
| | Hallucinogens | 1 | 2022 | 106 | 0.170 |
Why?
| | Infant, Premature, Diseases | 1 | 2022 | 103 | 0.170 |
Why?
| | Lip | 1 | 2020 | 24 | 0.170 |
Why?
| | Epithelium | 2 | 2023 | 316 | 0.170 |
Why?
| | Muscle, Skeletal | 5 | 2018 | 1739 | 0.170 |
Why?
| | Thrombocytopenia | 2 | 2020 | 198 | 0.170 |
Why?
| | Mutation Rate | 1 | 2020 | 31 | 0.170 |
Why?
| | Biopsy | 3 | 2021 | 1089 | 0.170 |
Why?
| | Pancreatic Neoplasms | 2 | 2019 | 853 | 0.170 |
Why?
| | Texas | 1 | 2021 | 251 | 0.160 |
Why?
| | Health Behavior | 2 | 2023 | 774 | 0.160 |
Why?
| | Multivariate Analysis | 1 | 2024 | 1488 | 0.160 |
Why?
| | Commission on Professional and Hospital Activities | 1 | 2020 | 4 | 0.160 |
Why?
| | Tendons | 1 | 2021 | 123 | 0.160 |
Why?
| | Breeding | 1 | 2020 | 65 | 0.160 |
Why?
| | Kidney Transplantation | 3 | 2013 | 701 | 0.160 |
Why?
| | Virus Assembly | 1 | 2020 | 79 | 0.160 |
Why?
| | Interferon Regulatory Factors | 1 | 2020 | 44 | 0.160 |
Why?
| | Blood Transfusion | 1 | 2022 | 337 | 0.160 |
Why?
| | Cell Surface Extensions | 1 | 2019 | 14 | 0.160 |
Why?
| | Extracellular Vesicles | 1 | 2022 | 147 | 0.160 |
Why?
| | Educational Measurement | 2 | 2020 | 289 | 0.160 |
Why?
| | Seawater | 1 | 2019 | 31 | 0.160 |
Why?
| | Albumins | 1 | 2020 | 115 | 0.160 |
Why?
| | Cleft Lip | 1 | 2020 | 56 | 0.160 |
Why?
| | Kidney Diseases | 1 | 2024 | 407 | 0.160 |
Why?
| | Enteral Nutrition | 1 | 2022 | 200 | 0.160 |
Why?
| | Fresh Water | 1 | 2019 | 57 | 0.160 |
Why?
| | Transfection | 3 | 2018 | 938 | 0.160 |
Why?
| | Maternal Health Services | 1 | 2021 | 101 | 0.160 |
Why?
| | China | 1 | 2020 | 212 | 0.160 |
Why?
| | Cleft Palate | 1 | 2020 | 72 | 0.160 |
Why?
| | Kidney Tubules, Proximal | 1 | 2020 | 132 | 0.160 |
Why?
| | Adult Stem Cells | 1 | 2019 | 40 | 0.160 |
Why?
| | Benchmarking | 1 | 2021 | 186 | 0.150 |
Why?
| | Fibrinogen | 1 | 2020 | 169 | 0.150 |
Why?
| | Zebrafish | 3 | 2022 | 500 | 0.150 |
Why?
| | Cysts | 1 | 2020 | 115 | 0.150 |
Why?
| | Specialties, Surgical | 1 | 2020 | 75 | 0.150 |
Why?
| | Satiety Response | 1 | 2019 | 11 | 0.150 |
Why?
| | Geography | 1 | 2019 | 202 | 0.150 |
Why?
| | Antineoplastic Agents, Immunological | 2 | 2018 | 190 | 0.150 |
Why?
| | Kingella kingae | 2 | 2009 | 12 | 0.150 |
Why?
| | Hyperphagia | 1 | 2019 | 40 | 0.150 |
Why?
| | Species Specificity | 1 | 2020 | 581 | 0.150 |
Why?
| | Brain | 3 | 2021 | 2725 | 0.150 |
Why?
| | Fimbriae, Bacterial | 2 | 2009 | 34 | 0.150 |
Why?
| | Staining and Labeling | 2 | 2012 | 155 | 0.150 |
Why?
| | Abnormalities, Multiple | 1 | 2020 | 195 | 0.140 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2018 | 32 | 0.140 |
Why?
| | Self Report | 1 | 2023 | 832 | 0.140 |
Why?
| | Violence | 1 | 2021 | 267 | 0.140 |
Why?
| | Exons | 2 | 2021 | 353 | 0.140 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2025 | 619 | 0.140 |
Why?
| | Lipid Metabolism | 1 | 2022 | 523 | 0.140 |
Why?
| | Hydrogels | 1 | 2025 | 679 | 0.140 |
Why?
| | Child | 7 | 2024 | 21833 | 0.140 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2018 | 55 | 0.140 |
Why?
| | Predictive Value of Tests | 2 | 2021 | 2017 | 0.140 |
Why?
| | Harassment, Non-Sexual | 1 | 2018 | 1 | 0.140 |
Why?
| | Indoles | 2 | 2019 | 409 | 0.140 |
Why?
| | RNA, Viral | 2 | 2020 | 688 | 0.140 |
Why?
| | Drug Approval | 1 | 2018 | 87 | 0.140 |
Why?
| | Family Relations | 1 | 2018 | 91 | 0.140 |
Why?
| | Biomechanical Phenomena | 2 | 2018 | 814 | 0.140 |
Why?
| | Endodeoxyribonucleases | 1 | 2018 | 72 | 0.140 |
Why?
| | Bacterial Adhesion | 2 | 2008 | 101 | 0.140 |
Why?
| | Inclusion Bodies | 3 | 2023 | 28 | 0.140 |
Why?
| | Predatory Behavior | 2 | 2015 | 50 | 0.140 |
Why?
| | Nepal | 1 | 2017 | 30 | 0.140 |
Why?
| | Muscular Dystrophies, Limb-Girdle | 2 | 2008 | 6 | 0.140 |
Why?
| | Caveolae | 1 | 2017 | 18 | 0.140 |
Why?
| | Parkinson Disease | 1 | 2023 | 546 | 0.130 |
Why?
| | Fishes | 2 | 2015 | 110 | 0.130 |
Why?
| | Notochord | 1 | 2017 | 14 | 0.130 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2021 | 397 | 0.130 |
Why?
| | Lipids | 1 | 2022 | 673 | 0.130 |
Why?
| | Multimodal Imaging | 1 | 2018 | 113 | 0.130 |
Why?
| | Child, Preschool | 6 | 2024 | 11102 | 0.130 |
Why?
| | Fractures, Bone | 1 | 2022 | 393 | 0.130 |
Why?
| | Memory, Short-Term | 1 | 2019 | 256 | 0.130 |
Why?
| | Prostatic Neoplasms | 1 | 2025 | 1049 | 0.130 |
Why?
| | Hematopoiesis | 1 | 2018 | 193 | 0.130 |
Why?
| | Family | 1 | 2021 | 673 | 0.130 |
Why?
| | Mycobacterium marinum | 1 | 2016 | 4 | 0.130 |
Why?
| | Gene Flow | 1 | 2017 | 84 | 0.130 |
Why?
| | Fluorescein Angiography | 1 | 2017 | 160 | 0.130 |
Why?
| | Young Adult | 5 | 2025 | 13203 | 0.130 |
Why?
| | Observer Variation | 1 | 2017 | 349 | 0.130 |
Why?
| | Clinical Clerkship | 1 | 2018 | 104 | 0.130 |
Why?
| | Pancreatectomy | 1 | 2019 | 238 | 0.120 |
Why?
| | Alcoholism | 1 | 2023 | 798 | 0.120 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 48 | 0.120 |
Why?
| | Lymph Nodes | 1 | 2019 | 493 | 0.120 |
Why?
| | British Columbia | 1 | 2015 | 21 | 0.120 |
Why?
| | Platelet-Derived Growth Factor | 2 | 2006 | 92 | 0.120 |
Why?
| | Hypoglycemic Agents | 1 | 2025 | 1300 | 0.120 |
Why?
| | Learning | 1 | 2020 | 416 | 0.120 |
Why?
| | Hemorrhage | 1 | 2020 | 719 | 0.120 |
Why?
| | Adaptation, Physiological | 1 | 2019 | 551 | 0.120 |
Why?
| | Intestinal Mucosa | 2 | 2019 | 620 | 0.120 |
Why?
| | Accidental Falls | 1 | 2018 | 192 | 0.120 |
Why?
| | Cell Differentiation | 4 | 2021 | 1999 | 0.120 |
Why?
| | Mutation | 8 | 2018 | 3991 | 0.120 |
Why?
| | Simulation Training | 1 | 2017 | 109 | 0.120 |
Why?
| | Cannabis | 1 | 2022 | 495 | 0.120 |
Why?
| | Interprofessional Relations | 1 | 2018 | 288 | 0.120 |
Why?
| | Oxidative Stress | 1 | 2022 | 1319 | 0.110 |
Why?
| | Aged, 80 and over | 2 | 2025 | 7609 | 0.110 |
Why?
| | Mental Health | 1 | 2021 | 733 | 0.110 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 141 | 0.110 |
Why?
| | Poverty | 1 | 2019 | 521 | 0.110 |
Why?
| | Parenting | 1 | 2018 | 315 | 0.110 |
Why?
| | Myocardial Ischemia | 1 | 2016 | 257 | 0.110 |
Why?
| | Urine | 2 | 2012 | 58 | 0.110 |
Why?
| | Insulin | 1 | 2025 | 2404 | 0.110 |
Why?
| | Nerve Fibers, Myelinated | 1 | 2014 | 47 | 0.110 |
Why?
| | Indians, North American | 2 | 2010 | 642 | 0.110 |
Why?
| | Respiratory Syncytial Viruses | 1 | 2014 | 54 | 0.110 |
Why?
| | Motor Cortex | 1 | 2014 | 61 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2021 | 803 | 0.100 |
Why?
| | HIV Infections | 2 | 2024 | 2941 | 0.100 |
Why?
| | Kidney | 1 | 2021 | 1469 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2018 | 2022 | 0.100 |
Why?
| | Ubiquitin | 3 | 2009 | 72 | 0.100 |
Why?
| | Endoribonucleases | 1 | 2014 | 78 | 0.100 |
Why?
| | Adolescent Behavior | 1 | 2018 | 530 | 0.100 |
Why?
| | DNA Methylation | 1 | 2018 | 637 | 0.100 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2014 | 117 | 0.100 |
Why?
| | Fatty Acids | 1 | 2016 | 445 | 0.100 |
Why?
| | Sensitivity and Specificity | 1 | 2018 | 1941 | 0.100 |
Why?
| | Mitochondria | 1 | 2019 | 950 | 0.100 |
Why?
| | Wound Healing | 3 | 2021 | 343 | 0.100 |
Why?
| | Methylene Blue | 1 | 2012 | 23 | 0.100 |
Why?
| | Risk Factors | 4 | 2024 | 10319 | 0.100 |
Why?
| | Antisepsis | 1 | 2012 | 1 | 0.100 |
Why?
| | Pelvic Pain | 1 | 2012 | 35 | 0.100 |
Why?
| | Internship and Residency | 2 | 2020 | 1172 | 0.100 |
Why?
| | Heart | 1 | 2016 | 608 | 0.100 |
Why?
| | Chlorhexidine | 1 | 2012 | 24 | 0.100 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2014 | 125 | 0.090 |
Why?
| | Molecular Motor Proteins | 1 | 2012 | 46 | 0.090 |
Why?
| | Endometriosis | 1 | 2012 | 52 | 0.090 |
Why?
| | Neural Stem Cells | 1 | 2014 | 156 | 0.090 |
Why?
| | Myelin Sheath | 1 | 2014 | 166 | 0.090 |
Why?
| | Sleep | 1 | 2019 | 792 | 0.090 |
Why?
| | Recovery of Function | 1 | 2016 | 664 | 0.090 |
Why?
| | Oligodendroglia | 1 | 2014 | 178 | 0.090 |
Why?
| | Cell Line | 7 | 2018 | 2864 | 0.090 |
Why?
| | Equipment Contamination | 1 | 2012 | 68 | 0.090 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2019 | 2143 | 0.090 |
Why?
| | Mutation, Missense | 2 | 2010 | 340 | 0.090 |
Why?
| | Infant | 3 | 2022 | 9539 | 0.090 |
Why?
| | Tissue Engineering | 2 | 2025 | 425 | 0.090 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2018 | 632 | 0.090 |
Why?
| | Peptides | 4 | 2013 | 980 | 0.090 |
Why?
| | Myosin Heavy Chains | 1 | 2012 | 174 | 0.090 |
Why?
| | Myocardium | 1 | 2016 | 898 | 0.090 |
Why?
| | Program Evaluation | 2 | 2017 | 909 | 0.090 |
Why?
| | Oklahoma | 1 | 2010 | 13 | 0.090 |
Why?
| | Guam | 1 | 2010 | 14 | 0.090 |
Why?
| | Receptors, Progesterone | 1 | 2013 | 351 | 0.090 |
Why?
| | Multienzyme Complexes | 1 | 2010 | 69 | 0.080 |
Why?
| | DNA, Viral | 1 | 2012 | 368 | 0.080 |
Why?
| | Mice, Transgenic | 5 | 2024 | 2165 | 0.080 |
Why?
| | Cell Line, Tumor | 5 | 2025 | 3400 | 0.080 |
Why?
| | Microscopy, Immunoelectron | 2 | 2022 | 45 | 0.080 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2013 | 261 | 0.080 |
Why?
| | Muscle Weakness | 2 | 2010 | 92 | 0.080 |
Why?
| | Fish Diseases | 1 | 2010 | 17 | 0.080 |
Why?
| | Knowledge | 2 | 2021 | 56 | 0.080 |
Why?
| | Osteitis Deformans | 1 | 2009 | 7 | 0.080 |
Why?
| | Arthrogryposis | 1 | 2010 | 14 | 0.080 |
Why?
| | Fluorescent Antibody Technique | 2 | 2022 | 384 | 0.080 |
Why?
| | Health Care Reform | 1 | 2010 | 105 | 0.080 |
Why?
| | Anti-Infective Agents | 1 | 2012 | 236 | 0.080 |
Why?
| | RNA Polymerase Sigma 54 | 1 | 2009 | 3 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2022 | 2270 | 0.080 |
Why?
| | Immunohistochemistry | 3 | 2022 | 1718 | 0.080 |
Why?
| | Fimbriae Proteins | 1 | 2009 | 21 | 0.080 |
Why?
| | Computer Simulation | 2 | 2018 | 987 | 0.080 |
Why?
| | Case-Control Studies | 4 | 2022 | 3550 | 0.080 |
Why?
| | Frontotemporal Dementia | 1 | 2009 | 57 | 0.080 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4301 | 0.080 |
Why?
| | Luciferases | 1 | 2009 | 149 | 0.080 |
Why?
| | Norwalk virus | 1 | 2008 | 2 | 0.070 |
Why?
| | Macrophages | 1 | 2016 | 1544 | 0.070 |
Why?
| | Biological Assay | 1 | 2009 | 129 | 0.070 |
Why?
| | History, 21st Century | 1 | 2009 | 214 | 0.070 |
Why?
| | Dental Abutments | 1 | 2008 | 1 | 0.070 |
Why?
| | Denture, Partial, Immediate | 1 | 2008 | 2 | 0.070 |
Why?
| | Quadriceps Muscle | 1 | 2009 | 120 | 0.070 |
Why?
| | Dental Prosthesis Design | 1 | 2008 | 3 | 0.070 |
Why?
| | Dental Restoration Failure | 1 | 2008 | 7 | 0.070 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 5764 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2008 | 43 | 0.070 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2014 | 99 | 0.070 |
Why?
| | Incisor | 1 | 2008 | 19 | 0.070 |
Why?
| | Genes, Reporter | 1 | 2009 | 272 | 0.070 |
Why?
| | Haemophilus | 1 | 2008 | 7 | 0.070 |
Why?
| | Fas Ligand Protein | 1 | 2008 | 59 | 0.070 |
Why?
| | Maxilla | 1 | 2008 | 35 | 0.070 |
Why?
| | Cyclic GMP-Dependent Protein Kinases | 1 | 2008 | 4 | 0.070 |
Why?
| | Transcriptome | 1 | 2014 | 969 | 0.070 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2008 | 49 | 0.070 |
Why?
| | History, 20th Century | 1 | 2009 | 325 | 0.070 |
Why?
| | Computer-Aided Design | 1 | 2008 | 41 | 0.070 |
Why?
| | Adhesins, Bacterial | 1 | 2008 | 40 | 0.070 |
Why?
| | Models, Anatomic | 1 | 2008 | 84 | 0.070 |
Why?
| | Microscopy, Fluorescence | 2 | 2019 | 413 | 0.070 |
Why?
| | Gastroenteritis | 1 | 2008 | 68 | 0.070 |
Why?
| | Cell Membrane | 2 | 2016 | 713 | 0.070 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2008 | 129 | 0.070 |
Why?
| | Health Policy | 1 | 2010 | 396 | 0.070 |
Why?
| | Adenocarcinoma | 1 | 2013 | 881 | 0.060 |
Why?
| | Adolescent | 5 | 2025 | 21435 | 0.060 |
Why?
| | Molecular Sequence Data | 5 | 2010 | 2924 | 0.060 |
Why?
| | Myofibrils | 1 | 2006 | 48 | 0.060 |
Why?
| | Sentinel Surveillance | 1 | 2006 | 48 | 0.060 |
Why?
| | Population Surveillance | 1 | 2009 | 479 | 0.060 |
Why?
| | Bacterial Proteins | 2 | 2009 | 897 | 0.060 |
Why?
| | Bone Regeneration | 1 | 2006 | 26 | 0.060 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 5507 | 0.060 |
Why?
| | Periodontitis | 1 | 2006 | 53 | 0.060 |
Why?
| | Immune Tolerance | 1 | 2008 | 366 | 0.060 |
Why?
| | Follow-Up Studies | 4 | 2020 | 5121 | 0.060 |
Why?
| | Communicable Diseases, Emerging | 1 | 2006 | 40 | 0.060 |
Why?
| | Cells, Cultured | 2 | 2025 | 4155 | 0.060 |
Why?
| | Antilymphocyte Serum | 2 | 2021 | 60 | 0.060 |
Why?
| | Cytoskeletal Proteins | 1 | 2006 | 156 | 0.060 |
Why?
| | Phosphoproteins | 1 | 2008 | 340 | 0.060 |
Why?
| | Periodontal Diseases | 1 | 2006 | 61 | 0.060 |
Why?
| | Rabbits | 2 | 2022 | 765 | 0.060 |
Why?
| | Gelatin | 1 | 2025 | 52 | 0.060 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2008 | 447 | 0.060 |
Why?
| | Laboratories | 1 | 2006 | 107 | 0.060 |
Why?
| | Binge Drinking | 1 | 2025 | 45 | 0.060 |
Why?
| | Ecological Momentary Assessment | 1 | 2025 | 39 | 0.060 |
Why?
| | Neurons | 1 | 2014 | 1592 | 0.060 |
Why?
| | Bioprinting | 1 | 2025 | 30 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2021 | 3628 | 0.060 |
Why?
| | Methacrylates | 1 | 2025 | 117 | 0.060 |
Why?
| | Enterotoxins | 1 | 2004 | 88 | 0.060 |
Why?
| | Valosin Containing Protein | 3 | 2009 | 8 | 0.060 |
Why?
| | Interleukin-15 | 1 | 2025 | 100 | 0.050 |
Why?
| | Rats | 3 | 2025 | 5558 | 0.050 |
Why?
| | Smoke-Free Policy | 1 | 2024 | 13 | 0.050 |
Why?
| | Nephritis | 1 | 2004 | 24 | 0.050 |
Why?
| | Opportunistic Infections | 1 | 2004 | 46 | 0.050 |
Why?
| | Bacterial Toxins | 1 | 2004 | 104 | 0.050 |
Why?
| | Acridine Orange | 1 | 2004 | 4 | 0.050 |
Why?
| | Intestine, Large | 1 | 2004 | 14 | 0.050 |
Why?
| | Nucleocapsid Proteins | 1 | 2023 | 27 | 0.050 |
Why?
| | Risk Assessment | 2 | 2010 | 3438 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 785 | 0.050 |
Why?
| | Disease Outbreaks | 2 | 2022 | 417 | 0.050 |
Why?
| | Plasmids | 2 | 2018 | 359 | 0.050 |
Why?
| | Virulence Factors | 1 | 2004 | 160 | 0.050 |
Why?
| | Dopaminergic Neurons | 1 | 2023 | 69 | 0.050 |
Why?
| | Inclusion Bodies, Viral | 1 | 2002 | 3 | 0.050 |
Why?
| | Glycolysis | 1 | 2025 | 319 | 0.050 |
Why?
| | Orthopoxvirus | 1 | 2002 | 4 | 0.050 |
Why?
| | Viral Structural Proteins | 1 | 2002 | 13 | 0.050 |
Why?
| | Escherichia coli Proteins | 1 | 2004 | 199 | 0.050 |
Why?
| | Immunoblotting | 2 | 2016 | 306 | 0.050 |
Why?
| | Light | 1 | 2025 | 389 | 0.050 |
Why?
| | Adenine | 1 | 2025 | 299 | 0.050 |
Why?
| | Gene Deletion | 2 | 2018 | 390 | 0.050 |
Why?
| | Rejuvenation | 1 | 2022 | 19 | 0.050 |
Why?
| | Epithelial Cells | 1 | 2008 | 1100 | 0.050 |
Why?
| | HIV-1 | 1 | 2008 | 887 | 0.050 |
Why?
| | Vero Cells | 1 | 2022 | 85 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2025 | 864 | 0.050 |
Why?
| | Trastuzumab | 1 | 2022 | 96 | 0.050 |
Why?
| | Ki-67 Antigen | 1 | 2022 | 109 | 0.050 |
Why?
| | Fracture Healing | 1 | 2022 | 83 | 0.050 |
Why?
| | Clinical Trials, Phase II as Topic | 1 | 2021 | 71 | 0.050 |
Why?
| | Thymocytes | 1 | 2021 | 35 | 0.050 |
Why?
| | Kidney Tubular Necrosis, Acute | 1 | 2021 | 26 | 0.050 |
Why?
| | Gene Knockout Techniques | 1 | 2022 | 118 | 0.040 |
Why?
| | Intubation, Gastrointestinal | 1 | 2022 | 77 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2024 | 730 | 0.040 |
Why?
| | Biofilms | 1 | 2004 | 264 | 0.040 |
Why?
| | Impulsive Behavior | 1 | 2022 | 148 | 0.040 |
Why?
| | United Kingdom | 1 | 2022 | 317 | 0.040 |
Why?
| | Transcription Factors | 1 | 2009 | 1706 | 0.040 |
Why?
| | Treatment Outcome | 3 | 2021 | 10813 | 0.040 |
Why?
| | Fasting | 1 | 2022 | 282 | 0.040 |
Why?
| | Belgium | 1 | 2020 | 11 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2025 | 1145 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 668 | 0.040 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 118 | 0.040 |
Why?
| | Cooperative Behavior | 1 | 2023 | 457 | 0.040 |
Why?
| | CRISPR-Cas Systems | 1 | 2022 | 127 | 0.040 |
Why?
| | Recombination, Genetic | 2 | 2017 | 207 | 0.040 |
Why?
| | Graft Rejection | 1 | 2004 | 577 | 0.040 |
Why?
| | Quinazolines | 1 | 2022 | 249 | 0.040 |
Why?
| | Tendon Injuries | 1 | 2021 | 67 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 306 | 0.040 |
Why?
| | Colorado | 1 | 2010 | 4515 | 0.040 |
Why?
| | Escherichia coli | 1 | 2004 | 826 | 0.040 |
Why?
| | Chloroquine | 2 | 2010 | 52 | 0.040 |
Why?
| | Genetic Association Studies | 1 | 2022 | 373 | 0.040 |
Why?
| | Myofibroblasts | 1 | 2021 | 127 | 0.040 |
Why?
| | Platelet Aggregation | 1 | 2020 | 103 | 0.040 |
Why?
| | Endothelium | 1 | 2020 | 125 | 0.040 |
Why?
| | Patient Care | 1 | 2021 | 112 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1742 | 0.040 |
Why?
| | RNA Interference | 2 | 2013 | 468 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2022 | 351 | 0.040 |
Why?
| | Aggression | 1 | 2021 | 199 | 0.040 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 243 | 0.040 |
Why?
| | Contraception | 1 | 2021 | 161 | 0.040 |
Why?
| | Education | 1 | 2020 | 111 | 0.040 |
Why?
| | Neoadjuvant Therapy | 1 | 2022 | 407 | 0.040 |
Why?
| | Tissue Embedding | 1 | 2018 | 4 | 0.040 |
Why?
| | Microtubule-Associated Proteins | 2 | 2010 | 195 | 0.040 |
Why?
| | Pinocytosis | 1 | 2018 | 11 | 0.040 |
Why?
| | Energy Metabolism | 1 | 2025 | 920 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 625 | 0.040 |
Why?
| | Zebrafish Proteins | 1 | 2022 | 288 | 0.040 |
Why?
| | Electricity | 1 | 2018 | 23 | 0.040 |
Why?
| | Cell Culture Techniques | 1 | 2021 | 363 | 0.040 |
Why?
| | Mutation Accumulation | 1 | 2018 | 1 | 0.040 |
Why?
| | Clathrin | 1 | 2018 | 28 | 0.040 |
Why?
| | Digoxin | 1 | 2018 | 27 | 0.040 |
Why?
| | Hunger | 1 | 2019 | 54 | 0.040 |
Why?
| | Cultural Characteristics | 1 | 2018 | 65 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2022 | 491 | 0.040 |
Why?
| | Viral Load | 2 | 2012 | 499 | 0.040 |
Why?
| | Drosophila | 1 | 2019 | 154 | 0.040 |
Why?
| | GPI-Linked Proteins | 1 | 2018 | 76 | 0.040 |
Why?
| | Veins | 1 | 2018 | 65 | 0.040 |
Why?
| | Physician Assistants | 1 | 2020 | 94 | 0.040 |
Why?
| | Postpartum Period | 1 | 2021 | 342 | 0.040 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2022 | 541 | 0.040 |
Why?
| | Germ Cells | 1 | 2018 | 64 | 0.040 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2018 | 106 | 0.040 |
Why?
| | Decision Making | 1 | 2025 | 937 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2008 | 2679 | 0.030 |
Why?
| | Lymph Node Excision | 1 | 2019 | 168 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2025 | 3007 | 0.030 |
Why?
| | Lymphatic Metastasis | 1 | 2019 | 323 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1047 | 0.030 |
Why?
| | Computer-Assisted Instruction | 1 | 2018 | 69 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 401 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1032 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2018 | 175 | 0.030 |
Why?
| | Attitude of Health Personnel | 1 | 2025 | 1153 | 0.030 |
Why?
| | Self Efficacy | 1 | 2021 | 400 | 0.030 |
Why?
| | Prognosis | 2 | 2018 | 3966 | 0.030 |
Why?
| | Survival Analysis | 1 | 2020 | 1289 | 0.030 |
Why?
| | Microtubules | 1 | 2019 | 280 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2009 | 216 | 0.030 |
Why?
| | Signal Transduction | 2 | 2025 | 5060 | 0.030 |
Why?
| | Binding Sites | 1 | 2020 | 1316 | 0.030 |
Why?
| | Quality Improvement | 1 | 2025 | 1180 | 0.030 |
Why?
| | Schools, Medical | 1 | 2018 | 151 | 0.030 |
Why?
| | Isolated Heart Preparation | 1 | 2016 | 6 | 0.030 |
Why?
| | Faculty | 1 | 2018 | 151 | 0.030 |
Why?
| | Sarcolemma | 2 | 2007 | 42 | 0.030 |
Why?
| | Organizational Culture | 1 | 2018 | 150 | 0.030 |
Why?
| | Gene Expression Regulation, Bacterial | 2 | 2009 | 321 | 0.030 |
Why?
| | Mutant Proteins | 2 | 2007 | 103 | 0.030 |
Why?
| | Microfilament Proteins | 2 | 2008 | 133 | 0.030 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2016 | 122 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-sis | 2 | 2006 | 39 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1270 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 978 | 0.030 |
Why?
| | Patient Safety | 1 | 2020 | 320 | 0.030 |
Why?
| | Cues | 1 | 2018 | 315 | 0.030 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2021 | 639 | 0.030 |
Why?
| | Granuloma | 1 | 2016 | 96 | 0.030 |
Why?
| | Eating | 1 | 2019 | 395 | 0.030 |
Why?
| | Nutritional Status | 1 | 2018 | 352 | 0.030 |
Why?
| | California | 1 | 2017 | 440 | 0.030 |
Why?
| | Energy Intake | 1 | 2019 | 506 | 0.030 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2022 | 1038 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2021 | 1468 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2019 | 611 | 0.030 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2016 | 135 | 0.030 |
Why?
| | Collagen Type I | 2 | 2006 | 138 | 0.030 |
Why?
| | Necrosis | 1 | 2016 | 247 | 0.030 |
Why?
| | Stress, Mechanical | 1 | 2017 | 483 | 0.030 |
Why?
| | Placenta | 1 | 2021 | 752 | 0.030 |
Why?
| | Amino Acid Transport Systems, Basic | 1 | 2014 | 4 | 0.030 |
Why?
| | Cadherins | 1 | 2016 | 201 | 0.030 |
Why?
| | Focus Groups | 1 | 2018 | 532 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2016 | 301 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2019 | 964 | 0.030 |
Why?
| | Thy-1 Antigens | 1 | 2014 | 11 | 0.030 |
Why?
| | Interviews as Topic | 1 | 2018 | 802 | 0.030 |
Why?
| | Mentoring | 1 | 2017 | 153 | 0.030 |
Why?
| | Alleles | 1 | 2017 | 886 | 0.030 |
Why?
| | Channelrhodopsins | 1 | 2014 | 16 | 0.030 |
Why?
| | Activating Transcription Factor 6 | 1 | 2014 | 20 | 0.030 |
Why?
| | HeLa Cells | 2 | 2008 | 635 | 0.030 |
Why?
| | Corpus Callosum | 1 | 2014 | 70 | 0.030 |
Why?
| | Primates | 1 | 2014 | 136 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2018 | 1029 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2014 | 306 | 0.030 |
Why?
| | Emotions | 1 | 2019 | 561 | 0.030 |
Why?
| | Mycobacterium tuberculosis | 1 | 2016 | 317 | 0.030 |
Why?
| | Base Pairing | 1 | 2013 | 64 | 0.020 |
Why?
| | Blotting, Northern | 1 | 2013 | 201 | 0.020 |
Why?
| | Membrane Potential, Mitochondrial | 1 | 2013 | 73 | 0.020 |
Why?
| | Mitochondrial Membranes | 1 | 2013 | 39 | 0.020 |
Why?
| | Peritoneal Cavity | 1 | 2012 | 31 | 0.020 |
Why?
| | Nephritis, Hereditary | 1 | 2012 | 2 | 0.020 |
Why?
| | Cell Respiration | 1 | 2013 | 102 | 0.020 |
Why?
| | Cell Survival | 1 | 2016 | 1128 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2022 | 1706 | 0.020 |
Why?
| | Apoptosis | 1 | 2022 | 2551 | 0.020 |
Why?
| | Recombinant Proteins | 2 | 2006 | 1350 | 0.020 |
Why?
| | Progestins | 1 | 2013 | 80 | 0.020 |
Why?
| | Cerebral Infarction | 1 | 2012 | 48 | 0.020 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2012 | 198 | 0.020 |
Why?
| | RNA Splicing | 1 | 2014 | 270 | 0.020 |
Why?
| | Cell Lineage | 1 | 2014 | 352 | 0.020 |
Why?
| | Gene Expression Regulation | 1 | 2021 | 2583 | 0.020 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2012 | 66 | 0.020 |
Why?
| | Dietary Supplements | 1 | 2016 | 562 | 0.020 |
Why?
| | DNA | 1 | 2018 | 1448 | 0.020 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 269 | 0.020 |
Why?
| | Protein Transport | 1 | 2013 | 440 | 0.020 |
Why?
| | Muscle Denervation | 1 | 2010 | 9 | 0.020 |
Why?
| | Colchicine | 1 | 2010 | 23 | 0.020 |
Why?
| | Tubulin Modulators | 1 | 2010 | 10 | 0.020 |
Why?
| | Mitochondrial Proteins | 1 | 2013 | 257 | 0.020 |
Why?
| | Vinblastine | 1 | 2010 | 70 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2014 | 375 | 0.020 |
Why?
| | Hemorrhagic Septicemia, Viral | 1 | 2010 | 1 | 0.020 |
Why?
| | Mesomycetozoea | 1 | 2010 | 1 | 0.020 |
Why?
| | Mesomycetozoea Infections | 1 | 2010 | 1 | 0.020 |
Why?
| | Pacific Ocean | 1 | 2010 | 8 | 0.020 |
Why?
| | Qualitative Research | 1 | 2018 | 1428 | 0.020 |
Why?
| | Evolution, Molecular | 1 | 2014 | 517 | 0.020 |
Why?
| | Ulcer | 1 | 2010 | 34 | 0.020 |
Why?
| | Calcium | 1 | 2016 | 1182 | 0.020 |
Why?
| | Sequestosome-1 Protein | 1 | 2009 | 15 | 0.020 |
Why?
| | Genes, Dominant | 1 | 2010 | 97 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 4092 | 0.020 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2018 | 1364 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2013 | 737 | 0.020 |
Why?
| | Tissue Extracts | 1 | 2009 | 21 | 0.020 |
Why?
| | Population Dynamics | 1 | 2010 | 149 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 710 | 0.020 |
Why?
| | Age Distribution | 1 | 2010 | 397 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2010 | 391 | 0.020 |
Why?
| | Protein Structure, Quaternary | 1 | 2009 | 129 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2009 | 143 | 0.020 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2009 | 85 | 0.020 |
Why?
| | Fibroblasts | 1 | 2014 | 1000 | 0.020 |
Why?
| | Synovial Fluid | 1 | 2008 | 72 | 0.020 |
Why?
| | Caliciviridae Infections | 1 | 2008 | 20 | 0.020 |
Why?
| | Isoleucine | 1 | 2008 | 15 | 0.020 |
Why?
| | Blotting, Southern | 1 | 2008 | 75 | 0.020 |
Why?
| | Laparoscopy | 1 | 2012 | 445 | 0.020 |
Why?
| | Threonine | 1 | 2008 | 46 | 0.020 |
Why?
| | Monte Carlo Method | 1 | 2008 | 141 | 0.020 |
Why?
| | Antirheumatic Agents | 1 | 2010 | 291 | 0.020 |
Why?
| | Oxygen | 1 | 2013 | 953 | 0.020 |
Why?
| | Dimerization | 1 | 2008 | 197 | 0.020 |
Why?
| | Cohort Studies | 1 | 2018 | 5691 | 0.020 |
Why?
| | Myosins | 1 | 2008 | 135 | 0.020 |
Why?
| | Sirolimus | 1 | 2009 | 270 | 0.020 |
Why?
| | Respiratory Insufficiency | 1 | 2010 | 317 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2009 | 662 | 0.020 |
Why?
| | Cell Death | 1 | 2008 | 373 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2009 | 430 | 0.020 |
Why?
| | Stress, Physiological | 1 | 2010 | 450 | 0.020 |
Why?
| | Chronic Disease | 1 | 2012 | 1788 | 0.020 |
Why?
| | Connectin | 1 | 2006 | 35 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2014 | 2467 | 0.020 |
Why?
| | Guided Tissue Regeneration, Periodontal | 1 | 2006 | 1 | 0.020 |
Why?
| | Organ Specificity | 1 | 2007 | 307 | 0.020 |
Why?
| | Alveolar Bone Loss | 1 | 2006 | 9 | 0.020 |
Why?
| | Calcium Phosphates | 1 | 2006 | 29 | 0.020 |
Why?
| | Base Sequence | 1 | 2010 | 2180 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2007 | 157 | 0.020 |
Why?
| | Bone Substitutes | 1 | 2006 | 27 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2006 | 320 | 0.010 |
Why?
| | Genetic Engineering | 1 | 2006 | 93 | 0.010 |
Why?
| | Physical Conditioning, Animal | 1 | 2008 | 254 | 0.010 |
Why?
| | Models, Genetic | 1 | 2008 | 589 | 0.010 |
Why?
| | Muscles | 1 | 2006 | 331 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2013 | 2798 | 0.010 |
Why?
| | Caveolins | 1 | 2004 | 6 | 0.010 |
Why?
| | Periplasm | 1 | 2004 | 13 | 0.010 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2004 | 47 | 0.010 |
Why?
| | HT29 Cells | 1 | 2004 | 41 | 0.010 |
Why?
| | Caveolin 1 | 1 | 2004 | 22 | 0.010 |
Why?
| | Membrane Microdomains | 1 | 2004 | 35 | 0.010 |
Why?
| | Promoter Regions, Genetic | 1 | 2009 | 1236 | 0.010 |
Why?
| | Specimen Handling | 1 | 2006 | 181 | 0.010 |
Why?
| | Methylprednisolone | 1 | 2004 | 63 | 0.010 |
Why?
| | Antibodies, Viral | 1 | 2008 | 648 | 0.010 |
Why?
| | Regeneration | 1 | 2006 | 198 | 0.010 |
Why?
| | Papio | 1 | 2004 | 94 | 0.010 |
Why?
| | Virulence | 1 | 2004 | 266 | 0.010 |
Why?
| | Phosphorylation | 1 | 2008 | 1760 | 0.010 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2006 | 551 | 0.010 |
Why?
| | Muscle Contraction | 1 | 2006 | 435 | 0.010 |
Why?
| | Cowpox virus | 1 | 2002 | 2 | 0.010 |
Why?
| | Genetic Complementation Test | 1 | 2002 | 65 | 0.010 |
Why?
| | Drug Delivery Systems | 1 | 2006 | 357 | 0.010 |
Why?
| | Vaccinia virus | 1 | 2002 | 43 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 850 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2009 | 1455 | 0.010 |
Why?
| | Immunoglobulin A | 1 | 2004 | 214 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2009 | 1475 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2006 | 691 | 0.010 |
Why?
| | Protein Binding | 1 | 2008 | 2232 | 0.010 |
Why?
| | Gene Expression | 1 | 2007 | 1485 | 0.010 |
Why?
| | Public Health | 1 | 2006 | 581 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 528 | 0.010 |
Why?
| | Viral Proteins | 1 | 2002 | 361 | 0.010 |
Why?
| | Communication | 1 | 2006 | 922 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2004 | 863 | 0.010 |
Why?
| | Disease Progression | 1 | 2006 | 2722 | 0.010 |
Why?
| | Amino Acid Sequence | 1 | 2002 | 2158 | 0.010 |
Why?
| | Algorithms | 1 | 2006 | 1701 | 0.010 |
Why?
| | Incidence | 1 | 2004 | 2805 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 6818 | 0.010 |
Why?
| | Bacteria | 1 | 2004 | 867 | 0.010 |
Why?
|
|
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|